☆ 4.1 Review

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Treatment resistance in psychiatry: state of the art and new directions

Oliver D. Howes et al.

Summary: Treatment resistance is a common issue in psychiatric disorders, leading to increased healthcare burden and costs. Despite growing research attention, there are significant gaps in understanding and addressing this issue, with key outstanding problems including heterogeneity and lack of consensus criteria. Recommendations for future research include harmonisation of definitions and exploration of novel interventions to improve targeted and personalised therapeutic approaches.

MOLECULAR PSYCHIATRY (2022)

添加到收藏夹

Article Mathematical & Computational Biology

Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments

Luke A. McGuinness et al.

Summary: Despite the availability of numerous software options for evidence synthesis, there is currently no universal tool for generating figures to display and explore risk-of-bias assessments. However, tools such as the R programming environment and Shiny have made it easy to create new tools for producing evidence syntheses. The new tool robvis facilitates the rapid production of publication-quality risk-of-bias assessment figures and is available as an R package and web app.

RESEARCH SYNTHESIS METHODS (2021)

添加到收藏夹

Article Neurosciences

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine

Danilo De Gregorio et al.

Summary: A resurgence of interest in hallucinogens for the treatment of psychiatric disorders has emerged, with studies confirming the efficacy of ketamine in treating depression. Emerging evidence also suggests potential therapeutic properties of psilocybin, LSD, and MDMA for mental diseases.

JOURNAL OF NEUROSCIENCE (2021)

添加到收藏夹

Article Psychiatry

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial

Alan K. Davis et al.

Summary: The study showed that psilocybin therapy with psychological support is effective in treating MDD, building on previous findings in patients with cancer and depression, as well as in a nonrandomized study in patients with treatment-resistant depression.

JAMA PSYCHIATRY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials

Ana Sofia Vargas et al.

BIOMEDICINES (2020)

添加到收藏夹

Article Neurosciences

Replication and extension of a model predicting response to psilocybin

Suzanne L. Russ et al.

PSYCHOPHARMACOLOGY (2019)

添加到收藏夹

Article Psychology, Clinical

Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being

Natasha L. Mason et al.

JOURNAL OF PSYCHOACTIVE DRUGS (2019)

添加到收藏夹

Article Neurosciences

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Leor Roseman et al.

NEUROPHARMACOLOGY (2018)

添加到收藏夹

Article Neurosciences

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression

J. B. Stroud et al.

PSYCHOPHARMACOLOGY (2018)

添加到收藏夹

Article Cell Biology

Psychedelics Promote Structural and Functional Neural Plasticity

Calvin Ly et al.

CELL REPORTS (2018)

添加到收藏夹

Article Psychiatry

LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark

Jens Knud Larsen

NORDIC JOURNAL OF PSYCHIATRY (2017)

添加到收藏夹

Article Mathematical & Computational Biology

Introduction, comparison, and validation of Meta-Essentials: A free and simple tool for meta-analysis

Robert Suurmond et al.

RESEARCH SYNTHESIS METHODS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Robin L. Carhart-Harris et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Psychology, Multidisciplinary

Patients' Accounts of Increased Connectedness and Acceptance After Psilocybin for Treatment-Resistant Depression

Rosalind Watts et al.

JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance

Ricardo Jorge Dinis-Oliveira

DRUG METABOLISM REVIEWS (2017)

添加到收藏夹

Article Clinical Neurology

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Roland R. Griffiths et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Stephen Ross et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

Classic hallucinogens in the treatment of addictions

Michael P. Bogenschutz et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)

添加到收藏夹

Article Psychiatry

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin L. Carhart-Harris et al.

LANCET PSYCHIATRY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis

Y. Ma

MOLECULAR PSYCHIATRY (2015)

添加到收藏夹

Article Clinical Neurology

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Matthew W. Johnson et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2014)

添加到收藏夹

Article Clinical Neurology

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Teri S. Krebs et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2012)

添加到收藏夹

Article Psychology, Clinical

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients

B. R. Godlewska et al.

PSYCHOLOGICAL MEDICINE (2012)

添加到收藏夹

Article Psychology, Clinical

Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner

Michael Lyvers et al.

JOURNAL OF PSYCHOACTIVE DRUGS (2012)

添加到收藏夹

Article Psychiatry

Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies

Stephen Ross

PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)

添加到收藏夹

Review Clinical Neurology

Human hallucinogen research: guidelines for safety

M. W. Johnson et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

The pharmacology of psilocybin

T Passie et al.

ADDICTION BIOLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.